Accessibility Menu
Cronos Group logo

Cronos Group

(TSX) CRON

Current PriceCA$3.92
Market CapCA$1.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)+367%
5 Year-57%
1 Year+41%
1 Month+6%
Cronos Group last closing stock price
MetricPriceDate
Last closeCAD 3.882026-07-16
Cronos Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.27%CAD 3.932026-07-09
1 month+6.01%CAD 3.662026-06-16
3 month+4.86%CAD 3.702026-04-17
Year to date+7.78%CAD 3.602025-12-31
1 year+41.09%CAD 2.752025-07-16
3 year+57.72%CAD 2.462023-07-17
5 year-57.27%CAD 9.082021-07-16
Since inception+367.47%CAD 0.832014-12-18

Cronos Group Financials at a Glance

Market Cap

CA$1.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$159.47M

Net Income (TTM)

-$2.06M

EPS (TTM)

-CA$0.01

P/E Ratio

-546.48

Dividend

CA$0.00

Beta (Volatility)

1.31 (Average)

Price

CA$3.92

Volume

76,636

Open

CA$3.84

Previous Close

CA$3.88

Daily Range

CA$3.83 - CA$3.92

52-Week Range

CA$2.67 - CA$4.66

Estimated Earnings Date

Aug 6, 2026

CRON News

marijuana leaf on green background

Marijuana Stocks: 7 Facts About Cronos Group's Quarterly Earnings

Todd CampbellMay 9, 2019
Happy businessman

Why Cronos Group Inc. Stock Rose Higher in August

George Budwell, PhDSep 3, 2018

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cronos Group

Cronos Group Inc. operates as a diversified global cannabinoid enterprise, focusing on the cultivation, production, and commercialization of cannabis products. The company offers a range of hemp-derived supplements and cannabis-infused products for both medicinal and adult-use sectors.

Products and Services
  • Manufactures and distributes hemp-derived supplements and cosmetics
  • Offers cannabis products including dried flower, edibles, and extracts
  • Brands include Lord Jones, Happy Dance, PEACE NATURALS, and Spinach
Growth Outlook
  • Revenue increased to $44.5 million in Q1 2026, showing strong demand
  • Gross profit margin improved to 41.4% in the latest quarter
  • International exports to markets like Germany and Australia are expanding
Financial Highlights
  • Cash and cash equivalents reached $822.4 million as of Q1 2026
  • Net income of $13.5 million reported in Q1 2026, indicating profitability
  • Current ratio of 21.87 suggests strong liquidity position
Cronos Group Inc. has established itself as a key player in the cannabinoid industry, leveraging its diverse product offerings and strong brand presence. The company has shown promising growth, particularly in its revenue and profitability metrics, which are critical indicators for potential investors. With a robust cash position and expanding international markets, Cronos Group is well-positioned to capitalize on the growing demand for cannabis products. The company's focus on both medicinal and recreational markets further enhances its growth potential, making it an intriguing option for those interested in the evolving cannabis sector.
AI Generated • Jun 27, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

610

CEO

Michael Ryan Gorenstein

Website

www.thecronosgroup.com

Headquarters

Stayner, ON M5V 2H1, CA

CRON Financials

Key Financial Metrics (TTM)

Gross Margin

42.19%

Operating Margin

-7.77%

Net Income Margin

-1.29%

Return on Equity

-0.19%

Return on Capital

-1.63%

Return on Assets

-0.18%

Earnings Yield

-0.18%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$1.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

373.66M

Volume

76.64K

Avg. Volume

182.27K

Financials (TTM)

Gross Profit

$67.28M

Operating Income

-$12.39M

EBITDA

$47.83M

Operating Cash Flow

$38.88M

Capital Expenditure

-$12.43M

Free Cash Flow

$26.45M

Cash & ST Invst.

$822.44M

Total Debt

$1.31M

Cronos Group Performance Analysis

Cronos Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 112,934,48821.0%
20232023-12-31USD 117,748,0414.3%
20242024-12-31USD 161,128,03236.8%
20252025-12-31USD 204,824,33927.1%
Cronos Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-303.4%
Q32025-09-308.6%
Q42025-12-3124.4%
Q12026-03-31-1.7%
Cronos Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.58-56.6%
20232023-12-31USD -0.26-55.1%
20242024-12-31USD 0.15N/A
20252025-12-31USD -0.03N/A
Cronos Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-600.0%
Q32025-09-30167.0%
Q42025-12-31-107.2%
Q12026-03-31837.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$44.47M

+37.5%

Gross Profit

$18.42M

+38.8%

Gross Margin

41.42%

N/A

Market Cap

CA$1.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$2.38M

N/A

Employees

610

N/A

Net Income

$13.53M

+120.3%

EBITDA

$21.51M

+112.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$822.44M

-1.8%

Total Debt

$1.31M

-27.8%

Accounts Receivable

$52.41M

+65.0%

Inventory

$48.71M

+40.8%

Long Term Debt

$1.14M

+36.0%

Short Term Debt

$169.00K

-82.7%

Return on Assets

-0.18%

N/A

Return on Invested Capital

-1.10%

N/A

Free Cash Flow

$8.88M

+150.9%

Operating Cash Flow

$10.72M

+611.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WELL.TOWELL Health Technologies Corp.
CA$4.19-1.18%
GUD.TOKnight Therapeutics Inc.
CA$9.82+1.34%
TLRY.TOTilray Brands, Inc.
CA$6.06-0.82%
SIA.TOSienna Senior Living Inc.
CA$23.55+1.42%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
AALAmerican Airlines Group
$14.98-0.04%
INTCIntel
$95.04-0.02%
SOFISoFi Technologies
$17.28-0.00%

Questions About CRON

What is the current price of Cronos Group?

Cronos Group is trading at CA$3.92 per share.

What is the 52-week range for Cronos Group?

Over the past 52 weeks, Cronos Group has traded between CA$2.67 and CA$4.66.

How much debt does Cronos Group have?

As of the most recent reporting period, Cronos Group reported total debt of $1.83M.

How much cash does Cronos Group have on hand?

Cronos Group reported $1.15B in cash and cash equivalents in its most recent financial results.

What is Cronos Group’s dividend yield?

Cronos Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services